logo

EbookBell.com

Most ebook files are in PDF format, so you can easily read them using various software such as Foxit Reader or directly on the Google Chrome browser.
Some ebook files are released by publishers in other formats such as .awz, .mobi, .epub, .fb2, etc. You may need to install specific software to read these formats on mobile/PC, such as Calibre.

Please read the tutorial at this link:  https://ebookbell.com/faq 


We offer FREE conversion to the popular formats you request; however, this may take some time. Therefore, right after payment, please email us, and we will try to provide the service as quickly as possible.


For some exceptional file formats or broken links (if any), please refrain from opening any disputes. Instead, email us first, and we will try to assist within a maximum of 6 hours.

EbookBell Team

Key Statistical Concepts In Clinical Trials For Pharma 1st Edition J Rick Turner Auth

  • SKU: BELL-4392560
Key Statistical Concepts In Clinical Trials For Pharma 1st Edition J Rick Turner Auth
$ 31.00 $ 45.00 (-31%)

0.0

0 reviews

Key Statistical Concepts In Clinical Trials For Pharma 1st Edition J Rick Turner Auth instant download after payment.

Publisher: Springer-Verlag New York
File Extension: PDF
File size: 1.95 MB
Pages: 61
Author: J. Rick Turner (auth.)
ISBN: 9781461416616, 9781461416623, 1461416612, 1461416620
Language: English
Year: 2012
Edition: 1

Product desciption

Key Statistical Concepts In Clinical Trials For Pharma 1st Edition J Rick Turner Auth by J. Rick Turner (auth.) 9781461416616, 9781461416623, 1461416612, 1461416620 instant download after payment.

This Brief discusses key statistical concepts that facilitate the inferential analysis of data collected from a group of individuals participating in a pharmaceutical clinical trial, the estimation of their clinical significance in the general population of individuals likely to be prescribed the drug if approved, and the related decision-making that occurs at both the public health level (by regulatory agencies when deciding whether or not to approve a new drug for marketing) and the individual patient level (by physicians and their patients when deciding whether or not the patient should be prescribed a drug that is on the market). These concepts include drug safety and efficacy, statistical significance, clinical significance, and benefit-risk balance.

Related Products